Besides, they identified a cluster of cytotoxic GZMB CD4+ T cells that expressed high levels of PDCD1 and CTLA4, suggesting that this population could be involved in the anti-tumor response after immunotherapy. This evidence concerns the gene CTLA4 and neoplasm.